Approval · Notice of Compliance 8436 · 2006
PROVOCHOLINE: Notice of Compliance 8436
Issued November 30, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8436
- Date
- November 30, 2006
- Company
- Methapharm Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 1600 mg powder for dilution per 50 ml vial, and other changes to the product monograph
- Therapeutic class
- Cholinergic / diagnostic aid (bronchial asthma)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROVOCHOLINE | 02288826 | Marketed |
Medicinal ingredients
- METHACHOLINE CHLORIDE 1,600 MG per VIAL